This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
Company News for Feb 27, 2026
by Zacks Equity Research
Companies In The Article Are:NVAX,SJM,SHAK,ACMR
SJMNegative Net Change NVAXNegative Net Change ACMRPositive Net Change SHAKNegative Net Change
consumer-staples medical retail
New Strong Buy Stocks for February 27th
by Zacks Equity Research
NABZY, DVA, FOR, RUN and ONTO have been added to the Zacks Rank #1 (Strong Buy) List on February 27, 2026.
DVANegative Net Change FORNegative Net Change NABZYNegative Net Change RUNNegative Net Change ONTOPositive Net Change
finance medical oil-energy
New Strong Sell Stocks for February 27th
by Zacks Equity Research
BKV, BMI and BFLY have been added to the Zacks Rank #5 (Strong Sell) List on February 27, 2026.
BMINegative Net Change BFLYPositive Net Change BKVNegative Net Change
medical
Best Value Stocks to Buy for February 27th
by Zacks Equity Research
PAX, DVA and ACT made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 27, 2026.
DVANegative Net Change ACTPositive Net Change PAXPositive Net Change
medical
Best Growth Stocks to Buy for February 27th
by Zacks Equity Research
DVA, ALL, and PAX it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 27, 2026.
DVANegative Net Change ALLNegative Net Change PAXPositive Net Change
medical
UnitedHealth vs. Humana: Which Healthcare Stock Has More Upside Now?
by Rajshree Sipani
UNH's scale and diversified model are likely to offer stronger upside than HUM as rising medical costs test managed care margins.
UNHPositive Net Change HUMNegative Net Change
artificial-intelligence healthcare hmo insurance insurance-premium medical smart-health
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
by Zacks Equity Research
A posts Q1 revenue growth and beats sales estimates, but margin pressure and earnings miss send shares lower in pre-market trade.
ANegative Net Change AVGONegative Net Change ATNIPositive Net Change CRDOPositive Net Change
earnings medical
Teladoc Tops Q4 Earnings Estimates on International Growth & Lower Costs
by Zacks Equity Research
TDOC posts narrower-than-expected Q4 loss, topping revenue estimates as international and Integrated Care strength offset BetterHelp weakness.
THCNegative Net Change HCAPositive Net Change ENSGPositive Net Change TDOCNegative Net Change
earnings medical
GEHC Unveils AI LOGIQ Ultrasound Systems to Boost Imaging & Workflow
by Zacks Equity Research
GE HealthCare unveils next-gen LOGIQ ultrasound systems with AI and Verisound Digital tech, targeting liver disease and faster workflows to boost diagnostic precision.
ISRGNegative Net Change CAHPositive Net Change VCYTNegative Net Change GEHCNegative Net Change
medical medical-devices
Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up
by Zacks Equity Research
VTRS beats Q4 estimates on 5% revenue growth, boosted by strong Brands sales and Greater China gains, while returning over $1B to shareholders in 2025.
ANIPPositive Net Change ALLONegative Net Change CSTLNegative Net Change VTRSPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals